In the big group of GBM, 152 tumors (40%) showed an O(6)-methylguanine-DNA methyltransferase (MGMT) promoter methylation, 46 (12.1%) were IDH1 mutated and 3 (0.8%) IDH2 mutated. This evidence concerns the gene IDH1 and glioblastoma.